L C Costantini

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease
    L C Costantini
    Neuroregeneration Laboratory, Harvard Medical School, McLean Hospital, Belmont, Massachusetts 02178, USA
    Neurobiol Dis 5:97-106. 1998
  2. ncbi Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors
    L C Costantini
    Neuroregeneration Laboratory, Harvard Medical School McLean Hospital, Belmont, MA 02178, USA
    Hum Gene Ther 10:2481-94. 1999
  3. ncbi Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease
    L C Costantini
    Neuroregeneration Laboratory, 115 Mill Street, Harvard Medical School/McLean Hospital, Belmont, MA 02178, USA
    Eur J Neurosci 13:1085-92. 2001
  4. ncbi Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum
    K H Holm
    Neuroregeneration Laboratory, McLean Hospital and Program in Neuroscience, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
    Neuroscience 104:397-405. 2001
  5. ncbi Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants
    L C Costantini
    Wadsworth Center for Laboratories and Research, University at Albany School of Public Health, New York State Department of Health, 12201 0509, USA
    Exp Neurol 145:214-27. 1997
  6. ncbi Immune parameters relevant to neural xenograft survival in the primate brain
    F Cicchetti
    Neuroregeneration Laboratories, Harvard Medical School McLean Hospital, Belmont, MA, USA
    Xenotransplantation 10:41-9. 2003

Collaborators

Detail Information

Publications6

  1. ncbi A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease
    L C Costantini
    Neuroregeneration Laboratory, Harvard Medical School, McLean Hospital, Belmont, Massachusetts 02178, USA
    Neurobiol Dis 5:97-106. 1998
    ....
  2. ncbi Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors
    L C Costantini
    Neuroregeneration Laboratory, Harvard Medical School McLean Hospital, Belmont, MA 02178, USA
    Hum Gene Ther 10:2481-94. 1999
    ..The effective and safe transgene delivery into the nigrostriatal system illustrates its potential for therapeutic application for neurologic disorders, such as Parkinson and Huntington disease...
  3. ncbi Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease
    L C Costantini
    Neuroregeneration Laboratory, 115 Mill Street, Harvard Medical School/McLean Hospital, Belmont, MA 02178, USA
    Eur J Neurosci 13:1085-92. 2001
    ..The effects of orally administered structurally related immunophilin ligands in acute and progressive models of DA degeneration are consistent with the idea that these compounds may have therapeutic value in PD...
  4. ncbi Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum
    K H Holm
    Neuroregeneration Laboratory, McLean Hospital and Program in Neuroscience, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
    Neuroscience 104:397-405. 2001
    ....
  5. ncbi Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants
    L C Costantini
    Wadsworth Center for Laboratories and Research, University at Albany School of Public Health, New York State Department of Health, 12201 0509, USA
    Exp Neurol 145:214-27. 1997
    ....
  6. ncbi Immune parameters relevant to neural xenograft survival in the primate brain
    F Cicchetti
    Neuroregeneration Laboratories, Harvard Medical School McLean Hospital, Belmont, MA, USA
    Xenotransplantation 10:41-9. 2003
    ..Graft survival correlated with high dose cyclosporine treatment, complete complement blockade and the absence of an induced PAMA response to the murine anti-C5 monoclonal antibodies...